Home / Combining DNA-repair gene mutations and molecular subtyping for more accurate prediction of outcome after neoadjuvant chemotherapy for bladder cancer
Combining DNA-repair gene mutations and molecular subtyping for more accurate prediction of outcome after neoadjuvant chemotherapy for bladder cancer
Batista Da Costa J. 1,
Seiler R. 2,
Ikeda K. 1,
Zhou J. 1,
Winters B. 3,
Gibb E. 4,
Volik S. 1,
Wright J. 3,
Sommerland M. 5,
Douglas J. 5,
Collins C. 1,
Black P. 1
1
University of British Columbia, Dept. of Urologic Sciences, Vancouver, Canada 2
University of Bern, Dept. of Urology, Bern, Switzerland 3
University of Washington School of Medicine, Dept. of Urology, Seattle, United States of America 4
GenomeDX Biosciences, Dept. of R&D, Vancouver, Canada 5
University Hospital of Southampton, Dept. of Urology, Southampton, United Kingdom
